Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3

Journal of Clinical Pathology

Volumn 61, Issue 8, 2008, Pages 958-961

  Tzankov, A ^a,e   Sotlar, K ^b   Muhlematter, D ^c   Theocharides, A ^a   Went, P ^a   Jotterand, M ^c   Horny, H P ^d   Dirnhofer, S ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d Institute of Pathology   (Germany)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; CARBOPLATIN; CD135 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; HYDROXYUREA; IFOSFAMIDE; STEM CELL FACTOR; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CODON; DIARRHEA; DRUG WITHDRAWAL; GENE; GENE LOCUS; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPIGMENTATION; ISCHEMIA; LEUKOPENIA; MALE; MAST CELL; MUTATION; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PRURITUS; RASH; STEM CELL TRANSPLANTATION; SYSTEMIC MASTOCYTOSIS; WHOLE BODY RADIATION;

CHROMOSOMES, HUMAN, PAIR 13; FMS-LIKE TYROSINE KINASE 3; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSLOCATION, GENETIC;

EID: 49149127176     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2008.058073     Document Type: Article

References (10)

1. Valent P, Horny HP, Li CY, et al. Mastocytosis. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001:293-302.
2. Horny HP, Sotlar K, Sperr WR, et al. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol 2004;57:604-8.
3. Sperr WR, Walchshofer S, Horny HP, et al. Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val. Br J Haematol 1998;103:740-9.
4. Sotlar K, Fridrich C, Mall A, et al. Detection of c-kit point mutation Asp-816-> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia. Leuk Res 2002;26:979-84.
5. Sotlar K, Escribano L, Landt O, et al. One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 2003;162:737-46.
6. Kralovics R, Teo SS, Li S, et al. Acguisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood 2006;108:1377-80.
7. Thiele J, Kvasnicka HM, Facchetti F, et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005;90:1128-32.
8. Choudhary C, Müller-Tidow C, Berdel WE, et al. Signal transduction of oncogenic Flt3. Int J Hematol 2005;82:93-9.
9. Tzankov A, Heiss S. Myeloproliferative diseases with the recurrent t(8;9)(p23;p24) - reply. Hum Pathol 2006;37:500-2.
10. Vu HA, Xinh PT, Masuda M, et al. FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation. Leukemia 2006;20:1414-21.